Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ... Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
REFERENCES Ghribi O., Dewitt D. A., Forbes M. S., Herman M. M. and Savory J. (2001b) Co-involvement of 198 mitochondria and endoplasmic reticulum in regulation of apoptosis: changes in cytochrome-c, Bcl-2 and Bax in the hippocampus of Aluminium treated rabbits. Brain Res. 8, 764–773. Ghribi O., Herman M. M., DeWitt D. A., Forbes M. S. and Savory J. (2001c) Abeta(1–42) and aluminium induce stress in the endoplasmic reticulum in rabbit hippocampus, involving nuclear translocation of gadd 153 and NF-kappaB. Brain Res. Mol. Brain Res. 96, 30–38. Ghribi O., Herman M. M. and Savory J. (2002) The endoplasmic reticulum is the main site for Caspase-3 activation following aluminium-induced neurotoxicity in rabbit hippocampus. Neurosci. Lett. 324, 217–221. Giasson B. I. and Lee V. M. (2000) A new link between pesticides and Parkinson’s disease. Nat. Neurosci. 3, 1227–1228. Giasson B. I., Duda J. E., Murray I. V., Chen Q., Souza J. M., Hurtig H. I., Ischiropoulos H., Trojanowski J. Q. and Lee V. M. (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290, 985–989. Gibb W. R. and Lees A. J. (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 51, 745–752. Gitelman H. J., Aldernan F. R., Jurs-Lasky M. and Rockette H. E. (1995) Serum and urinary aluminum levels of workers in the aluminum industry. Ann. Occup. Hyg. 39, 181–191. Giuffra M. E., Sethy V. H., Davis T. L., Mouradian M. M. and Chase T. N. (1993) Milacemide therapy for Parkinson's disease. Mov. Disord. 8, 47–50. Glinka Y. Y. and Youdim M. B. (1995) Inhibition of mitochondrial complexes I and IV by 6- hydroxydopamine. Eur. J. Pharmacol. 292, 329–332. Glinka Y., Tipton K. F. and Youdim M. B. (1996) Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine. J. Neurochem. 66, 2004–2010.
REFERENCES Glinka Y., Tipton K. F. and Youdim M. B. H. (1998) Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine. Eur. J. Pharmacol. 351, 121–129. Goedert M. (2001) Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2, 492–501. Goetz M. E. and Gerlach M. (2004) Formation of radicals, in Brain damage and repair, (Herdegen T. and Delgado-Garcia J., eds), pp. 135–164,. Kluwer, London. Goldberg M. S., Fleming S. M., Palacino J. J., Cepeda C., Lam H. A., Bhatnagar A., Meloni E. G., Wu N., Ackerson L. C., Klapstein G. J., Gajendiran M., Roth B. L., Chesselet M. F., Maidment N. T., Levine M. S. and Shen J. (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem. 278, 43628–43635. Golub M. S., Germann S. L., Han B. and Keen C. L. (2000) Lifelong feeding of a high aluminum diet to mice. Toxicology 150, 107–117. Gómez M., Esparza J. L., Domingo J. L., Singh P. K. and Jones M. M. (1999) Chelation therapy in aluminum-loaded rats: influence of age. Toxicology 137, 161–168. Gómez M., Esparza J. L., Nogués M. R., Giralt M., Cabré M. and Domingo JL. (2005) Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration. Free Radic. Biol. Med. 38, 104–11. Gonçalves P. P. and Silva V. S. (2007) Does neurotransmission impairment accompany aluminium neurotoxicity? J. Inorg. Biochem. 101, 1291–1338. González-Muñoz M. J., Meseguer I., Sanchez-Reus M. I., Schultz A., Olivero R., Benedí R. J. and Sánchez-Muniz F. J. (2008) Beer consumption reduces cerebral oxidation caused by aluminum toxicity by normalizing gene expression of tumor necrotic factor alpha and several antioxidant enzymes. Food Chem. Toxicol. 46, 1111–1118. 199
- Page 173: SUMMARY
- Page 176 and 177: SUMMARY values were attained at 48
- Page 178 and 179: SUMMARY neurodegeneration in the DA
- Page 181 and 182: CONCLUSIONS The results obtained in
- Page 183: 13) Aluminium does affect neither M
- Page 187 and 188: RESUMEN RESUMEN Desde el punto de v
- Page 189 and 190: RESUMEN zonas cerebrales excepto en
- Page 191: CONCLUSIONES
- Page 194 and 195: CONCLUSIONES Capítulo 2 4) La admi
- Page 196 and 197: CONCLUSIONES 172 En base a las conc
- Page 199 and 200: Publications as a direct result fro
- Page 201: REFERENCES
- Page 204 and 205: REFERENCES Agil A., Duran R., Barre
- Page 206 and 207: REFERENCES Baquet Z. C., Bickford P
- Page 208 and 209: REFERENCES 184 1,2,3,6-tetrahydropy
- Page 210 and 211: REFERENCES 186 compacta of the subs
- Page 212 and 213: REFERENCES Chung K. K., Dawson V. L
- Page 214 and 215: REFERENCES Davies K. J. (2001) Degr
- Page 216 and 217: REFERENCES Dhillon A. S., Tarbutton
- Page 218 and 219: REFERENCES Ekstrand M. I., Falkenbe
- Page 220 and 221: REFERENCES Fleming S. M., Delville
- Page 224 and 225: REFERENCES Good P. F., Olanow C. W.
- Page 226 and 227: REFERENCES Hamilton E. I., Miniski
- Page 228 and 229: REFERENCES Hirsch E. C., Brandel J.
- Page 230 and 231: REFERENCES Inden M., Kitamura Y., T
- Page 232 and 233: REFERENCES Johnson V. J. and Sharma
- Page 234 and 235: REFERENCES Kim W. G., Mohney R. P.,
- Page 236 and 237: REFERENCES Kuhn W., Winkel R., Woit
- Page 238 and 239: REFERENCES 214 K.D. and Polymeropou
- Page 240 and 241: REFERENCES Maraganore D. M., Lesnic
- Page 242 and 243: REFERENCES McCord J. M. and Fridovi
- Page 244 and 245: REFERENCES Miu A. C. and Benga O. (
- Page 246 and 247: REFERENCES Nair V. D., McNaught K.,
- Page 248 and 249: REFERENCES Onyango I. G. (2008) Mit
- Page 250 and 251: REFERENCES Perez F. A. and Palmiter
- Page 252 and 253: REFERENCES Przedborski S. and Goldm
- Page 254 and 255: REFERENCES Rifat S. L., Eastwood M.
- Page 256 and 257: REFERENCES Rymar V. V., Sasseville
- Page 258 and 259: REFERENCES Savory J., Herman M. M.
- Page 260 and 261: REFERENCES Shimizu H., Mori T., Koy
- Page 262 and 263: REFERENCES 238 the generation of hy
- Page 264 and 265: REFERENCES Taylor G. A., Moore P. B
- Page 266 and 267: REFERENCES Um J. W., Stichel-Gunkel
- Page 268 and 269: REFERENCES Vila M. and Przedborski
- Page 270 and 271: REFERENCES Whitehead M. W., Farrar
REFERENCES<br />
Ghribi O., Dewitt D. A., Forbes M. S., Herman M. M. and Savory J. (2001b) Co-<strong>in</strong>volvement <strong>of</strong><br />
198<br />
mitochondria and endoplasmic reticulum <strong>in</strong> regulation <strong>of</strong> apoptosis: changes <strong>in</strong><br />
cytochrome-c, Bcl-2 and Bax <strong>in</strong> the hippocampus <strong>of</strong> Alum<strong>in</strong>ium treated rabbits. Bra<strong>in</strong> Res.<br />
8, 764–773.<br />
Ghribi O., Herman M. M., DeWitt D. A., Forbes M. S. and Savory J. (2001c) Abeta(1–42) and<br />
<strong>alum<strong>in</strong>ium</strong> <strong>in</strong>duce <strong>stress</strong> <strong>in</strong> the endoplasmic reticulum <strong>in</strong> rabbit hippocampus, <strong>in</strong>volv<strong>in</strong>g<br />
nuclear translocation <strong>of</strong> gadd 153 and NF-kappaB. Bra<strong>in</strong> Res. Mol. Bra<strong>in</strong> Res. 96, 30–38.<br />
Ghribi O., Herman M. M. and Savory J. (2002) The endoplasmic reticulum is the ma<strong>in</strong> site for<br />
Caspase-3 activation follow<strong>in</strong>g <strong>alum<strong>in</strong>ium</strong>-<strong>in</strong>duced <strong>neurotoxicity</strong> <strong>in</strong> rabbit hippocampus.<br />
Neurosci. Lett. 324, 217–221.<br />
Giasson B. I. and Lee V. M. (2000) A new l<strong>in</strong>k between pesticides and Park<strong>in</strong>son’s disease. Nat.<br />
Neurosci. 3, 1227–1228.<br />
Giasson B. I., Duda J. E., Murray I. V., Chen Q., Souza J. M., Hurtig H. I., Ischiropoulos H.,<br />
Trojanowski J. Q. and Lee V. M. (2000) Oxidative damage l<strong>in</strong>ked to neurodegeneration by<br />
selective alpha-synucle<strong>in</strong> nitration <strong>in</strong> synucle<strong>in</strong>opathy lesions. Science 290, 985–989.<br />
Gibb W. R. and Lees A. J. (1988) The relevance <strong>of</strong> the Lewy body to the pathogenesis <strong>of</strong><br />
idiopathic Park<strong>in</strong>son’s disease. J. Neurol. Neurosurg. Psychiatry 51, 745–752.<br />
Gitelman H. J., Aldernan F. R., Jurs-Lasky M. and Rockette H. E. (1995) Serum and ur<strong>in</strong>ary<br />
alum<strong>in</strong>um levels <strong>of</strong> workers <strong>in</strong> the alum<strong>in</strong>um <strong>in</strong>dustry. Ann. Occup. Hyg. 39, 181–191.<br />
Giuffra M. E., Sethy V. H., Davis T. L., Mouradian M. M. and Chase T. N. (1993) Milacemide<br />
therapy for Park<strong>in</strong>son's disease. Mov. Disord. 8, 47–50.<br />
Gl<strong>in</strong>ka Y. Y. and Youdim M. B. (1995) Inhibition <strong>of</strong> mitochondrial complexes I and IV by 6-<br />
hydroxydopam<strong>in</strong>e. Eur. J. Pharmacol. 292, 329–332.<br />
Gl<strong>in</strong>ka Y., Tipton K. F. and Youdim M. B. (1996) Nature <strong>of</strong> <strong>in</strong>hibition <strong>of</strong> mitochondrial<br />
respiratory complex I by 6-hydroxydopam<strong>in</strong>e. J. Neurochem. 66, 2004–2010.